Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)
Others
Ratios

Creative Medical Technology Holdings (CELZ) Income from Continuing Operations (2016 - 2025)

Historic Income from Continuing Operations for Creative Medical Technology Holdings (CELZ) over the last 17 years, with Q3 2025 value amounting to -$1.2 million.

  • Creative Medical Technology Holdings' Income from Continuing Operations fell 1882.44% to -$1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.0 million, marking a year-over-year decrease of 1209.91%. This contributed to the annual value of -$5.5 million for FY2024, which is 391.38% down from last year.
  • As of Q3 2025, Creative Medical Technology Holdings' Income from Continuing Operations stood at -$1.2 million, which was down 1882.44% from -$1.2 million recorded in Q2 2025.
  • In the past 5 years, Creative Medical Technology Holdings' Income from Continuing Operations ranged from a high of $27.8 million in Q1 2021 and a low of -$6.2 million during Q4 2022
  • Over the past 5 years, Creative Medical Technology Holdings' median Income from Continuing Operations value was -$1.5 million (recorded in 2023), while the average stood at -$306298.2.
  • Over the last 5 years, Creative Medical Technology Holdings' Income from Continuing Operations had its largest YoY gain of 64378.54% in 2021, and its largest YoY loss of 56690.93% in 2021.
  • Quarter analysis of 5 years shows Creative Medical Technology Holdings' Income from Continuing Operations stood at -$3.9 million in 2021, then plummeted by 60.39% to -$6.2 million in 2022, then soared by 72.99% to -$1.7 million in 2023, then dropped by 10.46% to -$1.9 million in 2024, then skyrocketed by 33.34% to -$1.2 million in 2025.
  • Its last three reported values are -$1.2 million in Q3 2025, -$1.2 million for Q2 2025, and -$1.6 million during Q1 2025.